Effect of chronic antihypertensive treatment on ischemic lethal ventricular tachyarrhythmias and electrophysiological property in hypertrophied rat hearts
Effect of chronic antihypertensive treatment on ischemic lethal ventricular tachyarrhythmias and electrophysiological property in hypertrophied rat hearts
批准号:
03670431
负责人:
KOHYA Tetsuro
金额:
$1.28万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1991
资助国家:
日本
项目状态:
已结题
起止时间:
1991 至 1992
中文摘要
本研究的目的是验证左心室肥厚(LVH)消退可预防急性缺血时致死性室性心动过速引起的心源性猝死的假设。以自发性高血压大鼠(SIIR)心脏作为高血压性LVH模型,Wistar-Kyoto大鼠(WKY)心脏作为正常心脏模型。将SHR患者分为3组,分别为:1)不治疗(SHR), 2)卡托普利治疗(SHR- c), 3)肼嗪治疗(SHR- h)。从12周龄到18周龄,服用降压药6周。实验于18周龄进行。虽然SHR-C和SHR-H血压均降至正常水平,但只有SHR-C出现LVH消退。观察WKY组、SHR组、SHR- c组和SHR- h组左冠状动脉结扎术后30min致死性室性心动过速。持续性室性心动过速(VT)和心室颤动(Vf)的发生率在SHR合并LVH组明显高于WKY组。卡托普利治疗显著降低了VT/Vf的发生率,而肼嗪未能降低发生率。采用常规微电极技术进行电生理研究发现,SHR和SHR- h合并LVH组的动作电位持续时间(APD)明显长于WKY组,而静息电位、动作电位振幅和最大上冲程去极化速度变化不显著。在模拟缺血时,SHR和伴有LVH的SHR- h APD缩短幅度更大,而伴有LVH退化的SHR- c APD缩短幅度与WKY相似。这些结果表明,肥厚心脏在急性缺血期间更容易发生致死性室性心动过速,因为正常区和缺血区之间apd弥散度更大。退行性肥厚心脏电不均匀性的降低可以预防致命性室性心动过速引起的心源性猝死。少
英文摘要
The purpose of the study is to test the hypothesis that regression of left ventricular hypertrophy (LVH) prevents sudden cardiac death caused by lethal ventricular tachyarrhytmias during acute ischemia. Hearts from spontaneously hypertensive rats (SIIR) were used as a model of hypertensive LVH and those from Wistar-Kyoto rats (WKY) were served as normotensive hearts. SHRs were divided into 3 groups, as follows: 1) SHRs with no treatment (SHR), 2) SHRs treated with captopril (SHR-C), 3) SHRs treated with hydralazine (SHR-H). The antihypertensive agents were given for 6 weeks, from 12 to 18 weeks of age. Experiments were performed at 18 weeks of age. Although blood pressure in SHR-C and SHR-H were equally lowered to normal level, only SHR-C showed regression of LVH. Lethal ventricular tachyarrhythmias induced during 30 minutes after ligation of the left coronary artery were studied in the 4 groups (WKY, SHR, SHR-C and SHR-H). The incidence of sustained ventricular tachycardia (VT) and ve … More ntricular fibrillation (Vf) was significantly higher in SHR with LVH than in WKY. Treatment with captopril significantly reduced the incidence of VT/Vf although hydralazine failed to reduce the incidence. The electrophysiological study using conventional microelectrode techniques revealed that in SHR and SHR-H with LVH, action potential duration (APD) was much more prolonged than in WKY while resting potential, action potential amplitude and maximum upstroke velocity of depolarization did not change significantly. The APDs in SHR and SHR-H with LVH shortened to a greater extent during simulated ischemia, while in SHR-C with regressed LVH APD shortened only a little similar to that in WKY. These results suggest that hypertrophied hearts have a greater susceptibility to lethal ventricular tachyarrhythmias during acute ischemia because of greater APDs dispersion between the normal and ischemic zone. The reduction of electrical inhomogeneity in regressd hypertrophied hearts may prevent sudden cardiac death caused by lethal ventricular tachyarrhythmias. Less
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Tetsuro Kohya,Fumishi Tomita,Hisakazu Yasuda: "Characteristics and Clinical Significance of Silent Myocardial Ischemia during Ambulatory Electrocardiographic Monitoring in Patients with Ischemic Heart Disease" Jpn J Med. 29. 671-672 (1991)
Tetsuro Kohya、Fumishi Tomita、Hisakazu Yasuda:“缺血性心脏病患者动态心电图监测期间无症状心肌缺血的特征和临床意义”Jpn J Med。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
甲谷 哲郎.安田 寿一: "Silent Myocardial Ischemia (無症候性心筋虚血)の診断と治療" Jpn Circ J. 56. 1491-1494 (1992)
Tetsuro Kotani. Juichi Yasuda:“无症状心肌缺血的诊断和治疗”Jpn Circ J. 56. 1491-1494 (1992)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
The preventive effects of angiotensin II receptor blocker on lethal ventricular arrhythmias, a leading cause of sudden cardiac death, in experimental failing animal hearts
-
批准号:12670640
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2000
-
负责人:KOHYA Tetsuro
-
依托单位:
国内基金
海外基金
登录
查看更多内容
金钱草提取物激活AMPKa2/Nubp2通路抑制血管内皮细胞铁死亡在SHR大鼠中的降压作用及分子机制
-
批准号:JCZRLH202500881
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
基于 MAPK/ERK 信号通路 RDN 调控 miR-133
改善 SHR 大鼠急性心肌梗死的机制研究
-
批准号:TGD24H020002
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:蔡晓娜
-
依托单位:
SHR-SCR干细胞分子模块调控人参“铁线纹”形成机制的研究
-
批准号:82373987
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:刘娟
-
依托单位:
BR信号通过拮抗SHR功能时空决定根木质化的机制研究
-
批准号:32100293
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:王春华
-
依托单位:
BZR1与SHR协同调控拟南芥根尖干细胞活性的分子机制
-
批准号:32100267
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:田延臣
-
依托单位:
基于miRNA-9对下丘脑室旁核小胶质细胞P2X7受体的调节探讨电针对SHR大鼠交感神经兴奋性的影响
-
批准号:82074553
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:刘清国
-
依托单位:
拟南芥AtRAM1/SHR调控盐胁迫下根生长发育的分子机制
-
批准号:31900241
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:董寰
-
依托单位:
SHR和CIF协同调控植物根系凯氏带形成的机制
-
批准号:31900169
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2019
-
负责人:李朋雪
-
依托单位:
黄连解毒汤调控SHR内质网应激通路的分子机制研究
-
批准号:81860831
-
项目类别:地区科学基金项目
-
资助金额:37.0万元
-
批准年份:2018
-
负责人:岳桂华
-
依托单位:
基于自噬—NLRP3炎症体途径探讨芪七连胶囊保护SHR血管内皮损伤的效应机制研究
-
批准号:81860841
-
项目类别:地区科学基金项目
-
资助金额:35.0万元
-
批准年份:2018
-
负责人:罗远
-
依托单位: